Valeant Pharmaceuticals to Present at Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE: VRX) today announced members of its senior management team will make a presentation at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Thursday, June 12, 2008 at 8:00 a.m. PDT. The conference will be held at The Ritz-Carlton Laguna Niguel, Dana Point, California.
A live webcast and audio archive of the presentation will be available on the company’s Web site at www.valeant.com. Click on Investor Relations, and then the link to Financial Presentations. Participants should allow approximately five to ten minutes prior to the presentation’s start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast also can be accessed through the following URL:
http://cc.talkpoint.com/GOLD006/060908a_mg/?entity=valeant
About Valeant
Valeant Pharmaceuticals International (NYSE:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.
